NCT05943652

Brief Summary

The goal of this observational study is to learn about functional neurological disorders in patients with common non-functional movement disorders ("functional overlay"). The main questions it aims to answer are:

  • What is the frequency of functional neurological disorders in patients with non-functional movement disorders (functional overlay)?
  • What are the characteristics of functional neurological disorders in patients with non-functional movement disorders? Participants will be examined clinically and electrophysiologically, the examinations consist of:
  • a neurological examination
  • neuropsychological testing
  • electrophysiological tremor diagnostic
  • questionnaires about psychological, biological and social risk factors Researchers will compare patients with functional motor disorders to patients wit non-functional movement disorders to see if they differ from each other regarding the functional symptoms.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
216

participants targeted

Target at P75+ for all trials

Timeline
2mo left

Started Jan 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress96%
Jan 2023Jun 2026

Study Start

First participant enrolled

January 1, 2023

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

July 5, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 13, 2023

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Expected
Last Updated

September 29, 2025

Status Verified

September 1, 2025

Enrollment Period

3 years

First QC Date

July 5, 2023

Last Update Submit

September 23, 2025

Conditions

Keywords

AccelerometryPatient Health QuestionnaireNeuropsychology

Outcome Measures

Primary Outcomes (1)

  • Functional neurological symptoms

    Diagnosed by positive signs for functional neurological symptoms, as assessed in the neurological examination

    on average 30 minutes

Secondary Outcomes (21)

  • Duration of anamnesis

    1 to 3 minutes

  • Tremor diagnostic

    up to 20 minutes

  • Subjective quality of life

    5 minutes

  • Subjective health

    up to 10 minutes

  • Fatigue

    up to 5 minutes

  • +16 more secondary outcomes

Study Arms (6)

Parkinson Disease

Diagnostic Test: Neurological examinationDiagnostic Test: AnamnesisDiagnostic Test: Neuropsychological testingDiagnostic Test: QuestionnairesDiagnostic Test: Tremor recording

Idiopathic Dystonia

Diagnostic Test: Neurological examinationDiagnostic Test: AnamnesisDiagnostic Test: Neuropsychological testingDiagnostic Test: QuestionnairesDiagnostic Test: Tremor recording

Essential Tremor

Diagnostic Test: Neurological examinationDiagnostic Test: AnamnesisDiagnostic Test: Neuropsychological testingDiagnostic Test: QuestionnairesDiagnostic Test: Tremor recording

Functional Neurological Disorder

Diagnostic Test: Neurological examinationDiagnostic Test: AnamnesisDiagnostic Test: Neuropsychological testingDiagnostic Test: QuestionnairesDiagnostic Test: Tremor recording

Functional Cognitive Disorder

Diagnostic Test: Neurological examinationDiagnostic Test: AnamnesisDiagnostic Test: Neuropsychological testingDiagnostic Test: QuestionnairesDiagnostic Test: Tremor recording

Alzheimer Disease

Diagnostic Test: Neurological examinationDiagnostic Test: AnamnesisDiagnostic Test: Neuropsychological testingDiagnostic Test: QuestionnairesDiagnostic Test: Tremor recording

Interventions

A neurological examination following a protocol to detect positive signs of functional neurological disorders.

Alzheimer DiseaseEssential TremorFunctional Cognitive DisorderFunctional Neurological DisorderIdiopathic DystoniaParkinson Disease
AnamnesisDIAGNOSTIC_TEST

A standardized question about the patient´s history. The response time is measured. Question: "Could you tell me about the problems with the movement disorder you are experiencing?"

Alzheimer DiseaseEssential TremorFunctional Cognitive DisorderFunctional Neurological DisorderIdiopathic DystoniaParkinson Disease

Neuropsychological cognitive testing including: * Montreal Cognitive Assessment (MOCA) * Rey-Osterrieth Complex Figure Test (ROCFT) * Wechsler Memory Scale IV * Comprehensive Trail Making Test (CTMT) * semantic and phonematic fluency tests

Alzheimer DiseaseEssential TremorFunctional Cognitive DisorderFunctional Neurological DisorderIdiopathic DystoniaParkinson Disease
QuestionnairesDIAGNOSTIC_TEST

* Short Form 36 (SF 36) * Somatic Symptom Disorder - B Criteria Scale (SSD 12) * Patient Health Questionnaire 9 (PHQ 9) * Patient Health Questionnaire 15 (PHQ 15) * Generalized Anxiety Disorder 7 (GAD 7) * Fatigue Severity Scale (FSS) * Psychosomatic Competence Inventory (PSCI) * Work Ability Index (WAI) * Level of Personality Functioning Scale * Toronto Alexithymia Scale * Levels of Emotional Awareness Scale (short version) * Certainty About Mental States Questionnaire * Somatosensoric Amplification Scale * Personality Inventory for DSM-5 short version (PID5BF+M) * Childhood Trauma Questionnaire * European Quality of Life 5 Dimensions 5 Level Version (EQ5D5L)

Alzheimer DiseaseEssential TremorFunctional Cognitive DisorderFunctional Neurological DisorderIdiopathic DystoniaParkinson Disease
Tremor recordingDIAGNOSTIC_TEST

Accelerometry following a standardized protocol, using a triaxial accelerometer transducer (Biometrics ACL300, Sensitivity 6 100 mV/G, Biometrics Ltd, UK)

Alzheimer DiseaseEssential TremorFunctional Cognitive DisorderFunctional Neurological DisorderIdiopathic DystoniaParkinson Disease

Eligibility Criteria

Age18 Years - 18 Years
Sexall
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Patients with functional and non-functional movement disorders of the Movement Disorders Outpatient Clinic of the Department of Neurology, Medical University of Graz

You may qualify if:

  • Functional or non-functional movement disorder
  • to 80 years

You may not qualify if:

  • Patient is not able to consent
  • Patient is not able to understand / speak German fluently (questionnaires are available only in German)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University of graz

Graz, Styria, 8010, Austria

RECRUITING

MeSH Terms

Conditions

Conversion DisorderParkinson DiseaseTremorDystonia

Interventions

Neurologic ExaminationImmunologic Memory

Condition Hierarchy (Ancestors)

Somatoform DisordersMental DisordersParkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative DiseasesDyskinesiasNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, NeurologicalDiagnostic Techniques and ProceduresDiagnosisPhysical ExaminationAdaptive ImmunityImmunityImmune System Phenomena

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 5, 2023

First Posted

July 13, 2023

Study Start

January 1, 2023

Primary Completion

December 31, 2025

Study Completion (Estimated)

June 30, 2026

Last Updated

September 29, 2025

Record last verified: 2025-09

Locations